Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 13, 1980
[Cytotoxic drugs in the treatment of rheumatoid arthritis]P H de Mulder, L B van de Putte, F W Gribnau
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Dyspnea in cancer: causes and symptomatic treatment]D T Sleijfer, T S van der Werf, P H de Mulder
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckA S Planting, P H de Mulder, A de Graeff, et al.
International Journal of Cancer|July 9, 1992
Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumorsV Mattijssen, L T Balemans, P A Steerenberg, et al.
The Netherlands Journal of Medicine|February 1, 1993
Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapyC Kramers, P H de Mulder, J D Barth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Gemcitabine: a phase II study in patients with advanced renal cancerP H De Mulder, L Weissbach, G Jakse, et al.
Blut|April 1, 1981
Spontaneous lymphocyte transformation in relation to the number of circulating lymphocytes in Hodgkin's diseaseP H de Mulder, B E de Pauw, D J Wagener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomaG Stoter, S B Kaye, P H de Mulder, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 4, 1995
[Pathogenesis of tumor metastases]D J Ruiter, P H de Mulder, J A Schalken, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancerC J Punt, P H de Mulder, J T Burghouts, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Nederlands Tijdschrift Voor Geneeskunde|December 13, 1980
[Cytotoxic drugs in the treatment of rheumatoid arthritis]P H de Mulder, L B van de Putte, F W Gribnau
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1999
[Dyspnea in cancer: causes and symptomatic treatment]D T Sleijfer, T S van der Werf, P H de Mulder
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckA S Planting, P H de Mulder, A de Graeff, et al.
International Journal of Cancer|July 9, 1992
Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumorsV Mattijssen, L T Balemans, P A Steerenberg, et al.
The Netherlands Journal of Medicine|February 1, 1993
Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapyC Kramers, P H de Mulder, J D Barth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Gemcitabine: a phase II study in patients with advanced renal cancerP H De Mulder, L Weissbach, G Jakse, et al.
Blut|April 1, 1981
Spontaneous lymphocyte transformation in relation to the number of circulating lymphocytes in Hodgkin's diseaseP H de Mulder, B E de Pauw, D J Wagener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomaG Stoter, S B Kaye, P H de Mulder, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 4, 1995
[Pathogenesis of tumor metastases]D J Ruiter, P H de Mulder, J A Schalken, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancerC J Punt, P H de Mulder, J T Burghouts, et al.
Pageof 14